Patients’ preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406

Authors

  • Go Makimoto Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
  • Katsuyuki Hotta Center of Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan;  Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan
  • Isao Oze Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan
  • Kiichiro Ninomiya Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
  • Masamoto Nakanishi Department of Respiratory Medicine, Yamaguchi Ube Medical Center, Ube, Japan
  • Naofumi Hara Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
  • Hirohisa Kano Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
  • Hiromi Watanabe Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
  • Yusuke Hata Department of Respiratory Medicine, Kure Kyosai Hospital, Kure, Japan
  • Kazuya Nishii Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
  • Takamasa Nakasuka Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
  • Junko Itano Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
  • Takashi Ninomiya Health Service Center, Okayama University, Okayama, Japan
  • Toshio Kubo Center for Clinical Oncology, Okayama University Hospital, Okayama, Japan
  • Kadoaki Ohashi Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan
  • Eiki Ichihara Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan
  • Daisuke Minami Department of Respiratory Medicine, Okayama Medical Center, Okayama, Japan
  • Akiko Sato Department of Respiratory Medicine, Okayama Medical Center, Okayama, Japan
  • Masahiro Tabata Center for Clinical Oncology, Okayama University Hospital, Okayama, Japan
  • Yoshinobu Maeda Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
  • Katsuyuki Kiura Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan

DOI:

https://doi.org/10.1080/0284186X.2019.1679880

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2020-03-03

How to Cite

Makimoto, G., Hotta, K., Oze, I., Ninomiya, K., Nakanishi, M., Hara, N., … Kiura, K. (2020). Patients’ preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406. Acta Oncologica, 59(3), 324–328. https://doi.org/10.1080/0284186X.2019.1679880

Issue

Vol. 59 No. 3 (2020): Acta Oncologica

Section

Articles